In the midst of a pandemic, by order of the Government of the Russian Federation and by order of the Ministry of Industry and Trade of Russia, production of medical masks was arranged at the earliest possible date in Pochep branch of Moscow Endocrine Plant. From May 2020 to March 2021 about 395 million medical masks were produced at the facilities of Pochep branch.
The Enterprise has fulfilled the goal to provide the necessary number of medical products to Russian citizens, medical institutions and creating a reserve of these products.
At the same time, for many residents of the Bryansk region who lost their jobs during the pandemic, 750 new high-tech jobs with decent wages, created as a part of the organization of production, became a factor that determined financial stability. The budget of the Bryansk region was replenished by more than 125 million rubles due to tax revenues from the Enterprise.
To date, the peak of consumption of masks in the domestic market has already passed and Pochep branch of Moscow Endocrine Plant is switching to the scheduled mode of mask production. In this regard, from March 1, 2021, daily corporate transport, arranged at the initiative of the Enterprise, is canceled in conditions of work at maximum production capacity for the prompt delivery of workers from 9 districts of the Bryansk region.
Agreements were reached on arrangements of commercial trips of transport companies along the routes demanded by the employees of the Enterprise. Currently, about 200 employees have informed the management of the Company about their desire to terminate the employment relationship. The Enterprise makes additional payments to these employees on its own initiative.
Since May 4, 2021, the production of masks will switch from 24/7 to a reduced mode of operation. At the same time, one of the country's largest full-cycle medical mask production facilities maintains its base production load and maintains the ability to quickly mobilize maximum production capacity, if necessary. This applies to both the production of medical masks, including sterile products, which are in demand by the domestic health care system, regardless of the epidemiological situation in the country and the world, and the production of melt-blown filter material and components. The freed-up production capacities are redesigned with the aim of producing various hygiene products from nonwoven materials. A laboratory for quality control of medical masks and other nonwoven products was organized.
The management of the FSUE Moscow Endocrine Plant in the Pochep branch expresses gratitude to the residents of the Bryansk region, who came to production and mastered new competencies. The implementation of this project is largely due to the production personnel team. Together we managed to solve several socially significant problems. With the development of the production competencies of the Enterprise and the creation of new jobs, first of all, proposals for cooperation will be received by the reputable workers of the section for the production of medical masks.
In particular, in December 2021, the Pochep branch will organize a site for the production of drugs of the glucocorticosteroid group, which are in demand in the treatment of diseases associated with disorders of the immune system, as well as acute and chronic inflammatory diseases, including a number of socially significant diseases.
As part of the implementation of a strategically important departmental project, together with the Ministry of Industry and Trade of Russia, the FSUE Moscow Endocrine Plant in the Pochep branch will organize its own production of active pharmaceutical ingredients by 2023 with a capacity of more than 30 tons per year. This will make it possible to ensure independence from the import of substances in the production of both medicinal products of the Enterprise's nomenclature and a number of other medicinal products, most of which are included in the list of vital and essential medicinal products, ensuring full-cycle production, high quality, and affordability.
The project provides for the creation of more than 1,500 new jobs.
Comment type is not specified in the component properties.